Ocular Manifestation in Vasculitis systemic
Downloads
The case is presented below; 65-year-old female, who consults the emergency unit due to pain in the left eye of 20 days of evolution, is admitted to bed rest, an MRI is performed which shows an image suggestive of orbital abscess, antibiotic treatment is started but shows no improvement, she is evaluated by the rheumatology unit finding synovitis in bilateral carpal and II III metacarpophalangeal joints, When complementary immunological tests were performed, the condition was associated to a vasculitis with positive anti-neutrophil cytoplasmic antibodies (ANCAS), treatment was started and she was evaluated by the ophthalmology department, which reported retinal detachment, cellularity in anterior and posterior chamber of the left eye, so enucleation was performed.
Downloads
Domínguez R, Caballero C. Escleritis y vasculitis primarias sistémicas: a propósito de un caso. Rev. Méd. La Paz. 2021; 27(2): 49-51. http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1726-89582021000200049
2.
Barbosa R, Recillas C, Arellanes L. Manifestaciones oculares de las vasculitis primarias sistémicas. Reumatol Clin 2011; (7): 12-17. https://reumatologiaclinica.org/es-manifestaciones-oculares-vasculitis-primarias-sistemicas-articulo-S1699258X11002658
3.
Vargas D, Goecke A, Gatica H, Castro L, Wurmann P. Comportamiento clínico y factores asociados a mortalidad temprana en una cohorte de pacientes chilenos con vasculitis asociadas a anticuerpos anticitoplasma de neutrófilos (VAA). Rev. Méd. Chile. 2020; 148(6): 755-761. http://dx.doi.org/10.4067/S0034-98872020000600755
4.
Thayakaran R, Goel R, Adderley N. et al. Análisis grupal de pacientes con granulomatosis con poliangeítis (GPA) basado en síntomas de presentación clínica: un estudio de cohorte basado en la población del Reino Unido. Artritis Res Ther. 2022; (24): 201. https://doi.org/10.1186/s13075-022-02885-9
5.
Martínez G, Torres B, Rangel S, et al. Anticuerpos anticitoplasma del neutrófilo: Positividad y correlación clínica. Rev. Reumatol Clin. 2015; 11(1): 17-21. https://www.reumatologiaclinica.org/es-anticuerpos-contra-el-citoplasma-del-articulo-S1699258X14000576#/
6.
Ladrón D, Cerda F, Carreño A, Piottante A, Bitar P. Actualización en el estudio de Granulomatosis con poliangeitis (Granulomatosis de Wegener). Rev. chil. radiol. 2019; 25(1): 26-34. http://dx.doi.org/10.4067/S0717-93082019000100026.
7.
Pakalniskis M, Berg A, Policeni B, et al. The Many Faces of Granulomatosis With Polyangiitis: A Review of the Head and Neck Imaging Manifestations. AJR Am J Roentgenol. 2015; 205(6): 619–629. https://doi.org/10.2214/AJR.14.13864
Copyright (c) 2025 Herberth Leonardo, Isaac Gomez
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 |
This work is licensed under Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
| Copyright notice |
 |
Authors will retain their copyright and assign to the journal the right of first publication of their work, which will be simultaneously subject to a Creative Commons Attribution-Noncommercial-ShareAlike 4.0 International license (CC BY-NC-SA 4.0) that allows third parties to share the work as long as its author and its first publication in this magazine are indicated. |
|
Authors may adopt other non-exclusive license agreements for the distribution of the version of the published work (eg: deposit it in an institutional repository or publish it in a monographic volume) provided that the initial publication in this journal is indicated. |
|
Authors are allowed and recommended to disseminate their work through the internet (eg, in institutional telematic files or on their website) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The effect of open access). |
| About the Creative Commons license |
|
|
You are free to: |
|
Share — copy and redistribute the material in any medium or format. |
|
Adapt — remix, transform, and build upon the material. |
|
The licensor cannot revoke these freedoms as long as you follow the license terms. |
Under the following terms: |
 |
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. |
 |
NonCommercial — You may not use the material for commercial purposes. |
 |
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. |
| No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. |
